Research Projects
The World Mosquito Program (WMP; based at Monash University) has pioneered a novel biocontrol tool, Wolbachia, that controls the transmission of...
Supervisor: Dr. Johanna Fraser
Gastric cancer kills ~1 million people worldwide each year and has an average 5-year survival rate of 19%. It is, therefore, a cancer of unmet need....
Supervisor: Dr Dustin Flanagan
Pasteurella multocida is a Gram-negative bacterial pathogen that causes a number of different diseases in cattle,
pigs and poultry, resulting in...
Supervisor: Assoc Professor John Boyce
The mRNA therapeutics have emerged as a high potent new class of drug, revolutionizing disease treatments, such as therapeutic vaccines, monoclonal...
Supervisor: Nanoantibiotics - SHEN LAB
Antibiotic-resistance is a major problem in hospitals and different community settings. Dendritic cells are sentinel cells of the innate immune...
Supervisor: Assoc Professor Meredith O'Keeffe
Anorexia nervosa (AN) has clear biological underpinnings, however, the molecular mechanisms that lead to the development of this debilitating...
Supervisor: Dr Claire Foldi
This project aims to design, synthesize and evaluate a novel class of oligonucleotides. Oligonucleotides have emerged as a revolutionary tool in...
Supervisor: Dr Nitin Patil
Non-ribosomal peptide synthesis is a complex biosynthetic process that produces many medically important peptide natural products, including several...
Supervisor: Assoc Professor Max Cryle
Type 2 diabetes (T2D) is highly prevalent, with an estimated 370 million affected individuals worldwide, and this is predicted to double by 2030....
Supervisor: Professor Colby Zaph
Fibrosis is defined as the hardening and/or scarring of various organs including the heart and kidney, which usually results from abnormal wound...
Supervisor: Assoc Professor Chrishan Samuel
Current clinical management of obstructive sleep apnoea (OSA), a common sleep disorder in both children and adults, uses constant positive airway...
Supervisor: Associate Professor Brad Edwards
We have recently discovered a very potent antibody targeting the chemokine receptor CXCR3, a promising target for the treatment of inflammatory and...
Supervisor: Dr Remy Robert
The Monash Vision Group is developing a cortical vision prosthesis to restore vision to the blind. We currently have various projects focussed around...
Supervisor: Dr Yan Wong
The project aims to develop and deploy to the scientific community a robust method to target and isolate discrete regions within a frozen biological...
Supervisor: Assoc Professor Alex De Marco
Adaptive optics (AO) are used to improve the performance of optical systems. Through the use of AO, it is possible to compensate for any distortion...
Supervisor: Assoc Professor Alex De Marco
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease resulting in the destruction of the insulin-producing beta cells in the pancreas. T1D...
Supervisor: Dr Eliana Marino Moreno
Androgen deprivation therapy (ADT) is an important last-line treatment for advanced prostate cancer. ADT initially works well but eventually fails in...
Supervisor: Dr Renea Taylor
The functions of at least half of the proteins encoded in the genome of Plasmodium falciparum malaria parasites remain unknown. Understanding protein...
Supervisor: Professor Brian Cooke
Metabolite based T cell immunity is emerging as a major player in antimicrobial immunity, autoimmunity, metabolic diseases, and cancer. Namely,...
Supervisor: Dr Wael Awad
A high body mass index (a clinical measure of adiposity) at mid‐life is an acknowledged risk factor for Alzheimer’s dementia (AD). Potential...
Supervisor: Assoc Professor Siew Yeen Chai